National Biodefense Strategy and Implementation Plan [October 2022]: Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Secu
* Paperback Version * October, 2022 Release - Latest Version "NATIONAL BIODEFENSE STRATEGY AND IMPLEMENTATION PLAN FOR COUNTERING BIOLOGICAL THREATS, ENHANCING PANDEMIC PREPAREDNESS, AND ACHIEVING GLOBAL HEALTH SECURITY"
It is a vital interest of the United States to manage the risk of biological incidents, whether naturally occurring, accidental, or deliberate.
This action serves as a foundational component of the President’s vision to create a world free from catastrophic biological incidents, laying out a set of objectives to effectively counter the spectrum of biological threats . It defines biodefense as actions to counter biological threats, reduce biological risks, and prepare for, respond to, and recover from biological incidents, whether naturally occurring, accidental, or deliberate in origin and whether impacting human, animal, plant, or environmental health . It is broader than a Federal Government strategy; it is a call to action for state, local, tribal, and territorial (SLTT) entities, practitioners, physicians, scientists, educators, industry, and the international community to work together to elevate biological preparedness and response.
Biological threats can impact human, animal (domestic and wildlife), plant, and environmental health. They require an integrated approach that ensures the United States will address not only deliberate biological incidents as top national security priorities, but also epidemic and pandemic preparedness and global health security. The inclusion of naturally occurring and accidental biological threats underscores that our understanding of biodefense must be broader than only the threats posed by terrorist groups or adversaries seeking to use biological weapons. In today’s interconnected world, biological incidents anywhere can potentially have profound effects on physical and mental health and well-being in the United States and globally, cause significant morbidity and mortality, and disrupt livelihoods and economies, including domestic and international trade and travel.
Biological threats—whether naturally occurring, accidental, or deliberate in origin—are among the most serious threats facing the United States and the international community. As we have seen with the COVID-19 pandemic, biological incidents can cause extreme harm to the United States, including death, hospitalizations, disabilities, psychological trauma, and economic and social disruption on a massive scale.
The significant viral, bacterial, fungal, and other infectious disease outbreaks and toxin-related illnesses of recent decades impacting human, animal, and agricultural health, including COVID-19, continue to reveal that the financing cycle of panic and neglect must end. T here is significant and urgent need to achieve sustained investments and transformative improvements in the ability of both the U.S. Government and the international community to assess, prevent, prepare for, respond to, and recover from the next biological incident . Our capabilities must address the range of biological emerging and reemerging infectious diseases affecting humans, animals, plants, and the environment; risk of intentional misuse of advances in biotechnology; accidental release of biological agents; and threats posed by terrorist groups or adversaries seeking to use biological weapons.